Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. BGI Genomics Co., Ltd.
  6. News
  7. Sector news
    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-12-04
56.23 CNY   -4.61%
06:53aBGI Genomics to Sue Former Business Partner Over Claims of Faulty PCR Tests
MT
11/03Chinese COVID testing firms report big profits as virus fight intensifies
RE
10/28EU renews order for Illumina to keep Grail as separate entity
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Bio Diagnostics & Testing
12/05Insider Sell: Veracyte
MT
11/30Transcript : Exact Sciences Corporation Presents at Piper Sandler 34th Annual..
CI
11/29Transcript : Exact Sciences Corporation Presents at 5th Annual Evercore ISI H..
CI
11/18JPMorgan Chase Cuts Price Target on Guardant Health to $85 From $100, Maintains Overwei..
MT
11/17Insider Sell: Guardant Health
MT
11/15Transcript : Exact Sciences Corporation Presents at 13th Annual Jefferies Lon..
CI
11/14Piper Sandler Boosts Price Target for Exact Sciences to $50 From $40, Maintains Neutral..
MT
11/08Transcript : Exact Sciences Corporation Presents at Credit Suisse 31st Annual..
CI
11/08Transcript : Veracyte, Inc. Presents at Credit Suisse 31st Annual Healthcare ..
CI
11/07Stephens Adjusts Price Target on Guardant Health to $90 From $99, Maintains Overweight ..
MT
11/07Raymond James Adjusts Price Target on Exact Sciences to $60 From $70, Maintains Outperf..
MT
11/07BTIG Adjusts Price Target on Exact Sciences to $65 From $70, Maintains Buy Rating
MT
11/04Sector Update: Health Care Stocks Higher Amid Late Markets Advance
MT
11/04Sector Update: Health Care Stocks Sliding as Broader Markets Flit Between ..
MT
11/04Raymond James Adjusts Price Target on Veracyte to $27 From $31, Maintains Outperform Ra..
MT
11/04Credit Suisse Lowers Guardant Health's Price Target to $70 From $80, Keeps Outperform R..
MT
11/03Exact Sciences Q3 Loss Narrows as Sales Jump, Ups Revenue Guidance; Shares Jump After-H..
MT
11/03Guardant Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
11/03Exact Sciences Corporation Reports Earnings Results for the Third Quarter and Nine Mont..
CI
11/03Transcript : Exact Sciences Corporation, Q3 2022 Earnings Call, Nov 03, 2022
CI
11/03Transcript : Guardant Health, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
11/03Earnings Flash (EXAS) EXACT SCIENCES CORPORATION Reports Q3 Loss $-0.84
MT
11/03Earnings Flash (EXAS) EXACT SCIENCES CORPORATION Reports Q3 Revenue $523.1M, vs. Street..
MT
11/03Earnings Flash (EXAS) EXACT SCIENCES CORPORATION Reports Q3 Loss $-0.84, vs. Street Est..
MT
11/03Earnings Flash (GH) GUARDANT HEALTH Posts Q3 Loss $-1.18, vs. Street Est of $-1.08
MT
11/03Earnings Flash (GH) GUARDANT HEALTH Posts Q3 Revenue $117.4M, vs. Street Est of $117.9M
MT
11/03Exact Sciences Corporation Reports Impairment Charges for the Third Quarter Ended Septe..
CI
11/03Exact Sciences Corporation Revises Revenue Guidance for the Full Year of 2022
CI
11/03Guardant Health, Inc. Provides Earnings Guidance for the Full Year 2022
CI
11/03SVB Securities Adjusts Veracyte's Price Target to $35 From $30, Keeps Outperform Rating
MT
11/03Needham Adjusts Price Target on Veracyte to $33 From $31, Maintains Buy Rating
MT
11/03Earnings Reaction History: EXACT SCIENCES, 40.0% Follow-Throug..
MT
11/02Transcript : Veracyte, Inc., Q3 2022 Earnings Call, Nov 02, 2022
CI
11/02Earnings Flash (VCYT) VERACYTE Posts Q3 Revenue $75.6M
MT
11/02Earnings Flash (VCYT) VERACYTE Reports Q3 Loss $-0.12
MT
11/02Veracyte, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
CI
11/02Veracyte, Inc. Raises Revenue Guidance for the Year 2022
CI
11/01Piper Sandler Downgrades Guardant Health to Neutral From Overweight, Adjusts Price Targ..
MT
10/27Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Nine Months Ended..
CI
10/25Veracyte, Inc. Announces New Data Suggest Decipher GRID-Derived Genomic Signature Can H..
CI
10/24Veracyte, Inc. Announces Data That Provide New Insights into Thyroid Tumor Behavior
CI
10/19Exact Sciences Down Following Craig-Hallum Downgrade
MT
10/19Craig-Hallum Initiates Guardant Health at Buy With $88 Price Target
MT
10/19Craig-Hallum Downgrades Exact Sciences to Hold From Buy, Lowers Price Target to $35 Fro..
MT
10/18New Data Presented At American College of Chest Physicians 2022 Reinforce Clinical Valu..
CI
10/11Ark's Cathie Wood suggests Fed closer to 'pivot' as volatility rises
RE
10/10'Alarm Bells' Ring as China Shuffles Economic Leaders at Critical Time
MT
10/09Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced ..
CI
10/06Stephens Starts Guardant Health at Overweight With $99 Price Target
MT
09/22Veracyte's Decipher Prostate Genomic Classifier May Help Identify Aggressiveness of Pro..
MT
09/22Veracyte, Inc. Publishes New Data in JNCI Demonstrate its Decipher Prostate Genomic Cla..
CI
09/13Transcript : Exact Sciences Corporation Presents at Baird 2022 Global Healthc..
CI
09/13Transcript : Veracyte, Inc. Presents at Morgan Stanley 20th Annual Global Hea..
CI
09/13Veracyte, Inc. Names John Leite as Senior Vice President and General Manager of Pulmono..
CI
09/12Transcript : Guardant Health, Inc. Presents at Morgan Stanley 20th Annual Glo..
CI
09/11Veracyte, Inc. Announces That New Data from a Phase 3 Trial of the Multi-Center, Multi-..
CI
09/10Exact Sciences Corp. Demonstrates Power of Multi-Cancer Early Detection Approach with D..
CI
09/09Guardant Health Introduces GuardantINFINITY Smart Liquid Biopsy for Research Use to Hel..
CI
09/07Veracyte to Present Data Supporting Its Genomic Diagnostic Tool at Industry Conference
MT
09/06Guardant Health, Inc. to Showcase New Data At ESMO 2022 Demonstrating Utility of Its Po..
CI
09/01Revolution Medicines Appoints Jack Anders CFO, Daniel Simon Chief Business Officer
MT
08/31Guardant Health, Merck KGaA Expand Collaboration to Develop Precision Cancer Therapies
MT
08/31Guardant Health, Inc Expands Strategic Collaboration With Merck KGaA, Darmstadt, German..
CI
08/29Veracyte Says Study Indicates Microenvironments May Affect Large B-Cell Lymphoma Patien..
MT
08/29Veracyte, Inc. Announces New Data in Nature Medicine Suggest Pre-Treatment Tumor Microe..
CI
08/29Beijing Strong Biotechnologies, Inc. signed an Equity Transfer Agreement to acquire an ..
CI
08/26Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Half Year Ended J..
CI
08/25Credit Suisse Initiates Exact Sciences at Outperform with $55 Price Target
MT
08/25Credit Suisse Starts Guardant Health at Outperform with $80 Price Target
MT
08/19Insider Sell: Guardant Health
MT
08/18Piper Sandler Cuts Price Target on Exact Sciences to $40 From $50, Reiterates Neutral R..
MT
08/15Insider Sell: Guardant Health
MT
08/15Guardant Health Expands Detection Test to Include Breast, Lung Cancers; Shares Gain
MT
08/12Guardant Health Says FDA Approved Liquid Biopsy Test as Companion Diagnostic for Lung C..
MT
08/12Guardant Health, Inc. Receives FDA Approval for Guardant360« Cdx as Companion Diagnosti..
CI
08/11Veracyte, Inc. Appoints Eliav Barr to Its Board of Directors
CI
08/10Transcript : Guardant Health, Inc. Presents at UBS Genomics 2.0 and Medtech I..
CI
08/10Transcript : Exact Sciences Corporation Presents at UBS Genomics 2.0 and Medt..
CI
08/08Morgan Stanley Adjusts Guardant Health's Price Target to $80 From $85, Keeps Overweight..
MT
08/08Goldman Sachs Cuts Price Target on Guardant Health to $80 From $90, Maintains Buy Ratin..
MT
08/05Guardant Health Q2 Non-GAAP Loss Widens; Maintains 2022 Revenue Outlook
MT
08/04Earnings Flash (GH) GUARDANT HEALTH Posts Q2 Loss $-1.00
MT
08/04Earnings Flash (GH) GUARDANT HEALTH Posts Q2 Revenue $109.1M
MT
08/04Transcript : Guardant Health, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Guardant Health, Inc. Provides Earnings Guidance for the Full Year 2022
CI
08/04Guardant Health, Inc. Reports Earnings Results for the Second Quarter and Six Months En..
CI
08/04Raymond James Adjusts Veracyte's Price Target to $31 from $30 Keeps Outperform Rating
MT
08/04Goldman Sachs Cuts Price Target on Veracyte to $32 From $35, Noting Decline in Peer Mul..
MT
08/04Analyst recommendations: Illinois Tool Works, Eaton, Marathon Pe..
MS
08/03Craig Hallum Lowers Exact Sciences Price Target to $60 From $81, Maintains Buy Rating
MT
08/03BTIG Adjusts Price Target on Exact Sciences to $70 From $100, Reiterates Buy Rating
MT
08/03Cowen Adjusts Price Target on Exact Sciences to $67 From $83, Keeps Outperform Rating
MT
08/03Baird Adjusts Price Target on Exact Sciences to $75 From $90, Keeps Outperform Rating
MT
08/03Raymond James Adjusts Price Target on Exact Sciences to $70 From $80, Keeps Outperform ..
MT
08/03Citigroup Adjusts Price Target on Exact Sciences to $50 From $65, Maintains Neutral Rat..
MT
08/03Needham Adjusts Veracyte's Price Target to $31 From $26, Citing 'Peer Multiple Expansio..
MT
08/03MDxHealth Agrees to Buy Exact Sciences' Prostate Cancer Unit for Up to $100 Million
MT
08/03Belgium's MDxHealth To Buy Exact Sciences' Prostrate Cancer Test For $100 Million
MT
08/02Exact Sciences Corporation Reports Earnings Results for the Second Quarter and Six Mont..
CI
08/02Transcript : Exact Sciences Corporation, Q2 2022 Earnings Call, Aug 02, 2022
CI
Upcoming event on BGI GENOMICS CO., LTD.